Nanwei Medical disclosed its earnings forecast, expecting a net loss attributable to shareholders of 16 million yuan in the first half of 2026, compared with a loss of 12.9677 million yuan in the same period last year. The net loss after deducting non-recurring items is expected to be 16.7 million yuan, compared with a loss of 15.4003 million yuan a year earlier. The company stated that due to factors such as international trade policies, geopolitical situations, and rising comprehensive costs of cross-border logistics, some export orders have decreased year-on-year, and operating revenue is expected to decline slightly compared with the same period last year. Meanwhile, the nitrile glove business of its wholly-owned subsidiary Anhui Nanwei Medical Supplies Company Limited has been unable to fully release production capacity due to the industry market environment, and the high fixed amortization costs from earlier production line investments have led to a net loss.
Jiangsu Nanfang MedicalExport orders decreased due to trade policies and geopolitics, leading to expected revenue decline and loss.
Nitrile glove business unable to fully release production capacity due to industry environment, causing net loss.